Development and validation of the Nightingale Symptom Assessment Scale (N-SAS) and predictors of the quality of life of the cancer patients in Turkey
EUROPEAN JOURNAL OF ONCOLOGY NURSING, vol.15, no.1, pp.3-11, 2011 (SCI-Expanded, SSCI, Scopus)
- Publication Type: Article / Article
- Volume: 15 Issue: 1
- Publication Date: 2011
- Doi Number: 10.1016/j.ejon.2009.10.010
- Journal Name: EUROPEAN JOURNAL OF ONCOLOGY NURSING
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Social Sciences Citation Index (SSCI), Scopus
- Page Numbers: pp.3-11
- Istanbul University Affiliated: Yes
Abstract
Purpose: Treatment-related side effects have an adverse impact on the health-related quality of life (HRQoL) of cancer patients undergoing chemotherapy. This study is a description of the validity and responsiveness demonstrated by a new cancer and cancer treatment-specific symptom scale - the Nightingale Symptom Assessment Scale (N-SAS) - which was developed and validated to address the QoL of Turkish cancer patients.